MTOR and prion disease: In prion diseases, a significant reduction in PrPSc aggregates has been attained by mammalian Target of rapamycin (mTOR) dependent or independent induction of autophagy by using small molecules, like imatinib mesylate [118,119], lithium, rapamycin, trehalose, and sirtuin [120,121,122].